Clinical research in diabetes is one of the most dynamic fields of modern medicine. According to the International Diabetes Federation (IDF), more than 530 million people worldwide live with this condition, and the number is expected to rise in the coming years.
To deliver more effective and personalized therapies, it is crucial to conduct robust clinical trials capable of generating reliable and timely data. In this context, digital tools are transforming the way clinical data are collected and managed (IDF Diabetes Atlas).
The challenges of data collection in diabetes research
Diabetes trials involve a wide variety of data: blood glucose levels, HbA1c, body weight, laboratory results, concomitant therapies, and lifestyle information. Integrating these data streams is complex and, if done in a fragmented or non-standardized way, risks compromising study quality.
The American Diabetes Association (ADA) Standards of Care 2024 emphasize the importance of continuous glucose monitoring (CGM) and structured data collection to improve both clinical practice and research (ADA Standards of Care).
From paper to digital: eCRF and EDC
The transition from paper case report forms to electronic Case Report Forms (eCRF) managed via Electronic Data Capture (EDC) systems has revolutionized clinical research. These solutions enable researchers to:
- collect data in real time from trial sites,
- integrate digital devices such as CGM sensors and smart glucometers,
- apply automated quality checks with alerts for inconsistencies,
- centralize information in a secure, regulatory-compliant database.
The U.S. Food and Drug Administration (FDA) highlights in its guidance documents that electronic source data and validated digital tools ensure higher data integrity and audit readiness (FDA Guidance).
Benefits for sponsors, researchers, and patients
The adoption of digital platforms in diabetes clinical trials offers measurable benefits:
- Improved data quality, thanks to standardized forms and automated checks that reduce transcription errors.
- Operational efficiency, with remote monitoring reducing site visits and study costs.
- Better patient engagement, through ePRO and mobile applications that make participation easier and improve retention.
- Regulatory compliance, aligning with international standards such as ICH-GCP, GDPR, and FDA 21 CFR Part 11.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) also stresses the importance of high-quality, interoperable data in advancing diabetes research (NIDDK Research).
Ready to transform your diabetes clinical trials with digital innovation? Discover how ACTide can simplify data management.
ACTide: supporting diabetes research
ACTide, developed by Nubilaria, is designed to meet the modern demands of clinical research. Its modular architecture allows sponsors and investigators to manage every phase of a study, from protocol design to data collection and reporting.
For diabetes trials, ACTide provides:
- customizable eCRFs tailored to specific study protocols,
- seamless integration with digital monitoring devices and telemedicine apps,
- advanced data management tools, including audit trail and query management,
- support for multi-center and global studies.
By ensuring accurate and timely data, ACTide helps sponsors and researchers reduce complexity while improving study outcomes.
Looking ahead: the future of diabetes clinical research
Diabetes clinical research requires a leap forward in data management. Digital tools such as eCRF, EDC systems, and telemonitoring are no longer optional but essential for delivering reliable results and accelerating therapeutic innovation.
Discover how ACTide can support your next diabetes clinical trial